Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

B-Raf mutation: a key player in molecular biology of cancer.

Experimental and molecular pathology - 1 Dec 2013

Rahman M A, Salajegheh A, Smith R A, Lam A K-Y

Abstract excerpt

B-Raf is one of the more commonly mutated proto-oncogenes implicated in the development of cancers. In this review, we consider the mechanisms and clinical impacts of B-Raf mutations in cancer and discuss the implications for the patient in melanoma, thyroid cancer and colorectal cancer, where B-Raf mutations are particularly common.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Neoplasms
Share to Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24161954
DOI: 10.1016/j.yexmp.2013.10.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

B-Raf mutation: a key player in molecular biology of cancer.PMID 24161954Read ↗

Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedside.Semantic proximity Read ↗

Discovery of Raf Family Is a Milestone in Deciphering the Ras-Mediated Intracellular Signaling PathwaySemantic proximity Read ↗

Raf proteins and cancer: B-Raf is identified as a mutational target.Semantic proximity Read ↗

B-RAF: A contributor to the melanoma phenotype.Semantic proximity Read ↗

Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer.Semantic proximity Read ↗

Oncogenic B-Raf mutationsSemantic proximity Read ↗

Recent advances in B-RAF inhibitors as anticancer agents.Semantic proximity Read ↗

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.Semantic proximity Read ↗

RAF protein-serine/threonine kinases: structure and regulation.Semantic proximity Read ↗

Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma.Semantic proximity Read ↗

Guilty as charged: B-RAF is a human oncogene.Semantic proximity Read ↗

BRAFV600E: implications for carcinogenesis and molecular therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.